Sean Silcoff is a Technology and Life Sciences Reporter at the Globe and Mail. He covers Canadian tech, biotech, and innovation, with a focus on business and economics, including startups and AI. Sean has been featured in Space Today, Castanet Media, and The Globe and Mail, and is also the co-author of the award-winning book "Losing the Signal," which chronicles the rise and fall of BlackBerry.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Canada (National)
Not enough data
Sean Silcoff's coverage is heavily focused on national business and technology news, particularly in the Canadian market. He predominantly covers press releases, private sector announcements, government announcements, and investment analysis within the software & SaaS industry.
To effectively reach out to Sean, consider providing insights or exclusive information related to Canadian businesses and technology companies. Expert commentary from CEOs or industry leaders would likely be well-received given his focus on these areas. Additionally, if you have relevant data-backed analysis regarding stocks or investment trends specific to the Canadian market, it may capture his attention.
It's important that your pitches are tailored towards developments within Canada’s business landscape and encompass a strong technological component as per Sean's area of interest.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Sean Silcoff
Report an editorial error Report a technical issue Editorial code of conduct
By: Sean Silcoff
Report an editorial error Report a technical issue Editorial code of conduct
By: Sean Silcoff
Report an editorial error Report a technical issue Editorial code of conduct
By: Sean Silcoff
Engine Capital says it will refile notice by Wednesday to nominate six directors to seven-person board
By: Sean Silcoff
Four of its seven proposed directors at the Dec. 17 meeting would be newcomers to its board
By: Sean Silcoff
Report an editorial error Report a technical issue Editorial code of conduct
By: Sean Silcoff, Jeffrey Jones
Startup Jetson Home Inc. is a future-looking climate change play with ambitions to grow big by making heat pumps easier and cheaper to obtain
By: Sean Silcoff
D&D had rejected the activist shareholder’s original notice on technical grounds
By: Sean Silcoff
Report an editorial error Report a technical issue Editorial code of conduct Tickers mentioned in this story
By: Sean Silcoff
Jazz Pharmaceuticals says the U.S. Food and Drug Administration has approved use of the tumor-fighting antibody to treat adults with a form of biliary-tract cancer (BTC)
(833) 317-6278 
